Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 28, 2014
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 28, 2014

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/28/14 - "Endoprosthesis with Filament Repositioning of Retrieval Member and Guard Structure" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventors Tupil, Srinath; Biggins, James; Bertolino, William, filed on July 21, 2014, was made available online on November 13, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned
11/28/14 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the...
Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. In order to conduct educational and public information programs relating to tobacco use as authorized
11/28/14 - Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has entered into a Securities Purchase Agreement with Deerfield Management and certain of its affiliates pursuant to which Alimera will issue shares of preferred stock to Deerfield with a
11/28/14 - AstraZeneca Pharmaceuticals, Amylin Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Nov. 28 AstraZeneca Pharmaceuticals, Wilmington, Delaware, and Amylin Pharmaceuticals, San Diego, have been assigned a patent developed by 16 co-inventors for "GIP and exendin hybrid polypeptides." The co-inventors are Odile Esther Levy, San Diego, Alain D. Baron, San Diego, Lawrence J. D'Souza, San Diego, Mary Erickson, San Dieg
11/28/14 - AstraZeneca Pharmaceuticals, Amylin Pharmaceuticals Assigned Patent for Sustained Release Formulations Using Non-aqueous Carriers
ALEXANDRIA, Va., Nov. 28 AstraZeneca Pharmaceuticals, Wilmington, Delaware, and Amylin Pharmaceuticals, San Diego, have been assigned a patent developed by six co-inventors for the "sustained release formulations using non-aqueous carriers." The co-inventors are Mary L. Houchin, Rockville, Maryland, Robin H. Lee, San Diego, Hong Qi, San Diego, Gr
11/28/14 - BioMarin agrees to buy Dutch biotech company for up to $840 million [The Marin Independent Journal, Novato, Calif.]
Nov. 28 BioMarin agreed this week to buy Dutch biotech company Prosensa Holding N.V., a move intended to expand the Marin- based company's repertoire of drugs that fight rare diseases. It is under review by the U.S. Food and Drug Administration as is being fast-tracked for approval, BioMarin officials said. The deal also includes two additional $
11/28/14 - Cephalon Assigned Patent
ALEXANDRIA, Va., Nov. 28 Cephalon, Frazer, Pennsylvania, has been assigned a patent developed by Jason Edward Brittain, El Cajon, California, and Joe Craig Franklin, Tulsa, Oklahoma, for bendamustine pharmaceutical compositions. The patent application was filed on Dec. 19, 2012. Written by Sudarshan Harpal; edited by Jaya Anand.
11/28/14 - Concordia Healthcare Corp. Provides Clinical Trial and Corporate Update
-Concordia Healthcare Corp.,, announced today a clinical trial and corporate update, including the status of patient enrollment in its Phase 3 clinical trial to treat a rare form of bile duct cancer, and the entering into of an exclusive trademark license and product distribution agreement for China and other Asian territories with Union Med.
11/28/14 - Ipsen Announces FDA Acceptance of Filing for Dysport in the Treatment of Upper Limb Spasticity in Adult Patients
Ipsen today announced that the U.S. Food and Drug Administration has accepted for review its supplemental Biologics License Application for Dysport in the treatment of upper limb spasticity in adult patients. Marc de Garidel, Chairman and Chief Executive Officer of Ipsen stated The filing of Dysport in adult upper limb spasticity is an imp
11/28/14 - Long wait yet for Ebola vaccine [New Vision (Uganda)]
It will be months, at least, before a vaccine becomes available to tackle Ebola, experts have said as researchers reported success in early, safety tests with a leading candidate. A Phase I trial with the virus-based prophylactic carried by chimps showed it was "well-tolerated" by 20 healthy adults who generated antibodies and immune cells in respo
11/28/14 - Meeting essential needs [China Daily: Europe Weekly]
Essential drugs, or basic medicines, refers to a variety of medicines that are covered by the urban employee medical insurance in China. Merck Serono, a pharmaceutical company headquartered in Darmstadt, Germany, is actively involved in China's ongoing healthcare reforms, during which the essential drugs list is being revised. Allan Gabor, its pres
11/28/14 - New Medical Technology Study Findings Have Been Reported by D. Taylor and Co-Researchers (RFID in the Pharmaceutical Industry: Addressing...
Counterfeit drugs, however, remain a significant challenge for governments, pharmaceutical companies, clinicians, and patients and the use of RFID to track these compounds represents an opportunity for development. For more information on this research see: RFID in the Pharmaceutical Industry: Addressing Counterfeits with Technology. Journal of Med
11/28/14 - Purdue Pharma, Purdue Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Nov. 28 Purdue Pharma, Stamford, Connecticut, and Purdue Pharmaceuticals, Wilson, North Carolina, have been assigned a patent developed by four co-inventors for "tamper resistant dosage forms." The co-inventors are William H. McKenna, Yonkers, New York, Richard O. Mannion, Furlong, Pennsylvania, Edward P. O'Donnell, Basking Ridge
11/28/14 - Recent Findings from Duke University Provides New Insights into Health and Society (The Impact Of Specialty Pharmaceuticals As Drivers Of Health Care...
Recent Findings from Duke University Provides New Insights into Health and Society. The news correspondents obtained a quote from the research from Duke University, "They are frequently identified by having a cost to payers and patients of $600 or more per treatment. For more information on this research see: The Impact Of Specialty Pharmaceuticals
11/28/14 - RFS Pharma Assigned Patent
ALEXANDRIA, Va., Nov. 28 RFS Pharma, Tucker, Georgia, has been assigned a patent developed by Junxing Shi, Duluth, Georgia, for "2'- fluoronucleoside phosphonates as antiviral agents." The patent application was filed on March 22, 2007. Written by Deviprasad Jena; edited by Jaya Anand.
11/28/14 - U.S. Patents Awarded to Inventors in Oklahoma (Nov. 28)
ALEXANDRIA, Va., Nov. 28 The following federal patents were awarded to inventors in Oklahoma. ALEXANDRIA, Va., Nov. 28 Cephalon, Frazer, Pennsylvania, has been assigned a patent developed by Jason Edward Brittain, El Cajon, California, and Joe Craig Franklin, Tulsa, Oklahoma, for bendamustine pharmaceutical compositions. For more information ab
11/28/14 - White House On Clinical Trial of Ebola Vaccine Candidate [document]
Office of the Press Secretary. Francis Collins and Tony Fauci and their teams at the National Institutes of Health on the first published results from Phase 1 clinical trials of a promising Ebola vaccine candidate. The outstanding work of the Department of Health and Human Services' agencies NIH, the Centers for Disease Control and Prevention, th
11/27/14 - "Pharmaceutical Injection Device" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventors Murakami, Kenji; Fujimoto, Mitsuteru; Iio, Toshiaki, filed on December 11, 2012, was made available online on November 13, 2014, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent applicat
11/27/14 - "Smart Medicine Container" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventor Ratnakar, Nitesh, filed on July 22, 2014, was made available online on November 13, 2014, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent application has not been assigned to a company o
11/27/14 - Caldera Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Nov. 27 Caldera Pharmaceuticals, Los Alamos, New Mexico, has been assigned a patent developed by five co-inventors for an apparatus "for preparing samples for measurement by x-ray fluorescence spectrometry." The co-inventors are Eva R. Birnbaum, Los Alamos, New Mexico, Benjamin P. Warner, Los Alamos, New Mexico, Jennifer A. Berge
11/27/14 - Donations to Bellingham Herald?s Extend-a-Hand charity benefit local community [The Bellingham Herald (Bellingham, Wash.)]
Nov. 26 Two changes this year at Interfaith Community Health Center in Bellingham sharply increased the number of patients who received help with their prescriptions from Extend-a-Hand, The Bellingham Herald's community charity. Extend-a-Hand helps Interfaith patients with prescriptions and helps low-income residents find and keep rental housing.
11/27/14 - Drug firms seek new strategies [China Daily: Hong Kong Edition]
Pharmaceutical companies, especially multinationals, are looking for new ways to boost sales as China continues to crackdown on corruption. Following last year's bribery scandal involving British pharmaceutical giant GlaxoSmithKline, multinational pharmaceutical companies in China are watching their conduct in the market. The US-based company has..
11/27/14 - Drug firms seek new strategies [China Daily: US Edition]
Pharmaceutical companies, especially multinationals, are looking for new ways to boost sales as China continues to crackdown on corruption. Following last year's bribery scandal involving British pharmaceutical giant GlaxoSmithKline, multinational pharmaceutical companies in China are watching their conduct in the market. The US-based company has..
11/27/14 - Ebola Vaccine Seen as Safe in Initial Tests
The trial's aim is to determine the safety of the vaccine, produced by British firm GlaxoSmithKline. The chairman of Global Vaccines at GlaxoSmithKline, Dr. NIAID developed the vaccine with Okairos, a biotechnology company acquired by GlaxoSmithKline in 2013. The trial was conducted by the U.S. National Institutes of Health, of which NIAID is a par
11/27/14 - Experimental Ebola Vaccine Appears Safe, Prompts Immune Response [FARS News Agency]
TEHRAN- An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infe
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
HIV & AIDS Testing & Reporting Guidelines
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415